ClinicalTrialsFinder

Sodium-glucose Co-transporter-2 Inhibitors Clinical Trials in Toronto, Ontario

1 recruitingToronto, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 3

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Kidney DysfunctionEnd-stage Kidney DiseasePeritoneal Dialysis Complication+2 more
University Health Network, Toronto20 enrolled1 locationNCT05715814